Pharma & Biopharma Manufacturing

Isotopia Issues a call to action to the radionuclide Therapy industry.

The Lu-177 radiopharmaceuticals sector stands at a critical juncture, necessitating urgent collaboration. Our shared duty as supply chain stewards has neve...

 September 07, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company,  announced the completion of an $18 million Series Pre-A financing. The financ...

 September 04, 2023 | News

Elevating Energy Efficiency and Sustainability in the Pharmaceutical Industry

Explore an in-depth conversation with Jackson Seng as he sheds light on the successful partnership between Schneider Electric and Takeda, leading to the es...

 August 31, 2023 | News

Biocytogen Creates Divisions to Separate Preclinical Models and Antibody R&D

Biocytogen’s preclinical platforms include custom gene-editing services, generation of off-the-shelf humanized and/or immunodeficient animal and cell...

 August 31, 2023 | News

3B Scientific acquires iNNOGING Medical

iNNOGING Medical has developed the pioneering cloud-based SaaS solution e Sono for ultrasound simulation that enables users to train and analyze ...

 August 29, 2023 | News

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

Under the MOU, both parties agreed to cooperate for a successful supply of the vaccine. While Eubiologics, a developer and producer of Euvichol, takes char...

 August 28, 2023 | News

AGC Biologics Expands Cell Therapy Facilities at Longmont ATMP Campus

 AGC Biologics, the world's leading contract research and manufacturing organization (CDMO), announced the addition of three new Grade B cell therapy ...

 August 24, 2023 | News

Minghui Pharma Enrolls First Patient in Phase 3 Study for MH004 Cream in Atopic Dermatitis

The phase 3 clinical trial aims to evaluate the safety and efficacy of the investigational topical cream in a larger patient population. Leveraging the con...

 August 18, 2023 | News

CytoMed Collaborates for Improved Allogeneic CAR γδ T In Vivo Persistence in China

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its propr...

 August 16, 2023 | News

Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM

 Veeva Systems  announced that 18 of the top 20 biopharmas in Asia Pacific are using Veeva CRM for more effective engagement ...

 August 15, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

 August 11, 2023 | News

GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA

 GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering u...

 August 10, 2023 | News

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modi...

 August 09, 2023 | News

Oliver Welcomes Kenneth De Muynck as General Manager for Asia Pacific

Oliver is excited to announce the newest addition to its leadership team, with Kenneth De Muynck taking on the role of General Manager for Asia Pacific. Le...

 August 08, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close